Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136149

Published: 2020

Journal Articles

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Udo Zur Stadt, PhD, Malik Alawi, M. Sc., Gabriele Escherich, MD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2715.

https://doi.org/10.1182/blood.V130.Suppl_1.2715.2715

Published: 2017

Journal Articles

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Jessica I Hoell, MD, Sebastian Ginzel, MSc, Cornelia Eckert, PhD, Michael Gombert, PhD, Ute Fischer, PhD, Martin Stanulla, MD, Martin Schrappe, MD PhD, Udo zur Stadt, PhD, Peter Bader, MD, Brigitte Strahm, MD, Julia Alten, Anja Moericke, MD, Gabriele Escherich, MD, Arend Stackelberg, MD, Christina Peters, MD, Arndt Borkhardt, MD, Roland Meisel, MD

Blood (2016) 128 (22): 601.

https://doi.org/10.1182/blood.V128.22.601.601

Published: 2016

Journal Articles

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

Annabel Zoghbi, Beate Winkler, MD, Udo zur Stadt, PhD, Ingo Müller, MD, Gabriele Escherich, MD

Blood (2016) 128 (22): 5196.

https://doi.org/10.1182/blood.V128.22.5196.5196

Published: 2016

Journal Articles

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

Henning Fedders, PhD, Denis Martin Schewe, MD, Martin Zimmermann, PhD, Ameera Alsadeq, PhD, Anja Moericke, MD, Udo zur Stadt, PhD, Martin A. Horstmann, MD, Rob Pieters, MD PhD, Martin Schrappe, MD PhD, Gunnar Cario, MD, Martin Stanulla, MD

Blood (2015) 126 (23): 1417.

https://doi.org/10.1182/blood.V126.23.1417.1417

Published: 2015

Journal Articles

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Gabriele Escherich, MD, Udo zur Stadt, PhD, Malik Alawi, Martin A. Horstmann, MD

Blood (2015) 126 (23): 2609.

https://doi.org/10.1182/blood.V126.23.2609.2609

Published: 2015

Journal Articles

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

Anja Troeger, MD, Gabriele Escherich, MD, Udo zur Stadt, PhD, M. L Den Boer, MSc, PhD, Rob Pieters, MD, PhD, Martin Zimmermann, PhD, Ulrich Göbel, MD, PhD, Arndt Borkhardt, MD, PhD, Dagmar Dilloo, MD, PhD, Gritta Janka, MD, PhD

Blood (2008) 112 (11): 1520.

https://doi.org/10.1182/blood.V112.11.1520.1520

Published: 2008

Journal Articles

Defining the Leukemia Epigenome: Distinct Genome Wide Histone H3 Modification Patterns Exist in AML, ALL and Healthy Hematopoietic Progenitor Cells.

Carsten Muller-Tidow, MD, Claudia Homme, PhD, Hans-Ulrich Klein, Antje Hascher, PhD, Steffen Koschmieder, MD, Anke Becker, PhD, Yipeng Wang, PhD, Michael McClelland, PhD, Udo zur Stadt, PhD, Florian Battke, Kay Nieselt, PhD, Christian Thiede, MD, Gerhard Ehninger, MD, Wolfgang E. Berdel, MD, Martin Dugas, MD, Hubert Serve, MD

Blood (2007) 110 (11): 2124.

https://doi.org/10.1182/blood.V110.11.2124.2124

Published: 2007

Journal Articles

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Tomasz Szczepanski, MD, PhD, Vincent H.J. van der Velden, PhD, Pieter Van Vlierberghe, Bernd Gruhn, MD, PhD, Renate Panzer-Grumayer, MD, PhD, Monica Spinelli, Helene Cave, PhD, Udo zur Stadt, PhD, Dario Campana, MD, PhD, Andre Schrauder, MD, PhD, Elisabeth van Wering, PhD, Jules P.P. Meijerink, PhD, Jacques J.M. van Dongen, MD, PhD

Blood (2007) 110 (11): 1435.

https://doi.org/10.1182/blood.V110.11.1435.1435

Published: 2007

Journal Articles

Prognostic Impact of MRD in the Bone Marrow of Children at First Isolated Extramedullary Relapse of ALL.

Nikola Hanzsch, Cornelia Eckert, PhD, Cecile Acquaviva, PhD, Eva Fronkova, Arend von Stackelberg, MD, Udo zur Stadt, PhD, Andre Schrauder, MD, Jan Trka, PhD, MD, Karl Seeger, PhD, MD, Guenter Henze, MD, Helene Cave, PhD

Blood (2004) 104 (11): 1087.

https://doi.org/10.1182/blood.V104.11.1087.1087

Published: 2004

NARROW

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

Defining the Leukemia Epigenome: Distinct Genome Wide Histone H3 Modification Patterns Exist in AML, ALL and Healthy Hematopoietic Progenitor Cells.

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Prognostic Impact of MRD in the Bone Marrow of Children at First Isolated Extramedullary Relapse of ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only